Cognitive · Cognitive peptide (research)
Dihexa
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Also known as
- dihexapeptide, pnb-0408
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Dihexa is studied for
- Synaptogenesis (research)
- Cognitive support (research)
- Neurogenesis research (research)
Mechanism of action
Dihexa is being studied in the cognitive category. Investigational nootropic studied for synaptogenesis and cognition. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Dihexa?
Dihexa is a cognitive peptide. Investigational nootropic studied for synaptogenesis and cognition.
What is Dihexa studied for?
Published research has examined Dihexa for synaptogenesis, cognitive support, neurogenesis research. Human clinical evidence varies by indication.
Is Dihexa FDA-approved?
No. Dihexa is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Dihexa used in research?
Protocols vary by study. Dihexa is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Dihexa is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.